Ignite Creation Date:
2024-05-06 @ 2:03 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04209621
Status:
TERMINATED
Last Update Posted:
2022-03-09
First Post:
2019-12-21
Brief Title:
Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-22
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-21
First Submit QC Date:
December 21 2019
Study First Post Date:
2019-12-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-03-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-15
Last Update Post Date:
2022-03-09
Last Update Post Date Type:
ACTUAL